On April 29, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) announced a licensing agreement with Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, granting exclusive commercialization rights for its self-developed ipilimumab biosimilar HLX13 in the United States, 42 European countries and regions, Japan, Canada, and Australia.

Fakeeh Care Group has announced a strategic partnership with Fosun Pharma, a leading innovation-driven global healthcare company operating in the fields of pharmaceuticals, medical devices & diagnostics, and healthcare services. This partnership is part of Fakeeh Care Group’s ambitious vision to accelerate healthcare innovation in Saudi Arabia and align with the Saudi Vision 2030.

(Hong Kong, 25 April 2025) Fosun International Limited (HKEX stock code: 00656, “Fosun International”), together with its subsidiaries (“Fosun” or the “Group”), issued the Environmental, Social and Governance (ESG) Report 2024 (the “ESG Report”). Facing the increasingly severe challenges of global climate change, Fosun released its third Climate Information Disclosures Report with reference to the Part D of Appendix C2 of the Main Board Listing Rules (the “New Climate Requirements”) of the Hong Kong Stock Exchange, the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations and International Financial Reporting Standards S2 Climate-related Disclosures Requirements (“IFRS S2”).

(April 25, 2025, Shanghai, China) April 25 is World Malaria Day. The World Health Organization (WHO) theme for the 2025 World Malaria Day is Malaria Ends With Us: Reinvest, Reimagine, Reignite, aiming to re-energize efforts at all levels, from global policy to community action, to accelerate progress towards malaria elimination.

On 24 April 2025, Nanyang Commercial Bank (“NCB”) and Fosun International Limited (“Fosun International”, HKEX stock code: 00656) entered into a strategic cooperation agreement.

On 15 April 2025, S&P Global published the Sustainability Yearbook 2025 (China Edition). Fosun International Limited (HKEX stock code: 00656, “Fosun International”) was successfully included in S&P Global’s Sustainability Yearbook 2025 (China Edition) and was ranked top 1% for the second consecutive year, recognizing its continuous efforts in environmental, social and governance (ESG) over the years.

The year 2024 was marked by both challenges and opportunities for Fosun International (HKEX stock code: 0656). In response to a complex external environment, the Group adopted a prudent strategy focused on “business streamlining, strategic advancements and exits, and balanced investment and divestment”, divesting from some asset-heavy projects and reducing financial leverage. In addition, it continued to “focus on core businesses” and deepened industry operations to effectively adapt to market changes.

On April 15, 2025, Henlius (2696.HK) released the "2024 Environmental, Social, and Governance (ESG) Report" (hereinafter referred to as the "ESG Report" or "Report"). This marks the sixth consecutive year that the company has submitted an ESG-related report to global stakeholders, comprehensively showcasing Henlius’ remarkable achievements and steadfast commitment across 5 key ESG pillars: Product, Talent, Environment, Society, and Corporate Governance.

On April 11, Hong Kong’s most widely circulated newspapers, Headline Daily and Sing Tao Daily, published a full-page feature interview with Xu Xiaoliang, Co-CEO of Fosun International. The headline was titled “Focusing on Core Businesses and Achieving Balanced Investment and Divestment, Leveraging Globalization and Innovation to Drive Fosun’s Steady Development”.